Get started
Author

Meiyue Zhang

Observed name: M. Zhang
ORCID: 0009-0006-9381-1778
Observed ORCID: 0009-0006-9381-1778
OpenAlex ID: A5111296866
Impact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer
2021 · W. Yao, X. Zhao, et al. · ESMO Open · 35
PDF
Design, synthesis and biological evaluation of amphiphilic benzopyran derivatives as potent antibacterial agents against multidrug-resistant bacteria
2024 · Fangquan Liu, Siyu Yang, et al. · European Journal of Medicinal Chemistry · 14
Development of Xanthoangelol-Derived Compounds with Membrane-Disrupting Effects against Gram-Positive Bacteria
2024 · Siyu Yang, Fangquan Liu, et al. · Antibiotics · 11
Neoadjuvant chemoradiotherapy combined with immunotherapy: a promising strategy for MSS/pMMR locally advanced rectal cancer
2025 · Lei Yang, Jinhai Tang, et al. · Medical Oncology · 3
Combating Clinically Isolated Pathogens with Surfactin from a Newly Isolated Bacillus subtilis ZCK-1: from Strain Characterization to Therapeutic Potential
2025 · M. Zhang, J. Dong, et al. · Applied Biochemistry and Microbiology
Works count: 5
Citation count: 63
H-index: 3
I10-index: 3
Year
Topic
Type